Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples